X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Genomic Valley Biotech Ltd.
BSE CODE: 539206   |   NSE CODE: NA   |   ISIN CODE : INE574D01010   |   21-Nov-2024 Hrs IST
BSE NSE
Rs. 100.35
1.85 ( 1.88% )
 
Prev Close ( Rs.)
98.50
Open ( Rs.)
96.55
 
High ( Rs.)
100.35
Low ( Rs.)
96.55
 
Volume
7012
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Particulars Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Operational & Financial Ratios          
   Earnings Per Share (Rs)2.12  -0.03  -1.83  0.94  0.76  
   CEPS(Rs)2.15  0.25  -1.21  1.52  1.40  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)11.55  9.42  14.69  16.52  15.59  
   Tax Rate(%)0.09  -466.35  -11.41  -39.01  0.94  
Margin Ratios          
   Core EBITDA Margin(%)32.38  -534.82  -65.57  65.40  42.24  
   EBIT Margin(%)23.94  58.73  -155.09  45.97  24.08  
   Pre Tax Margin(%)23.83  -2.34  -241.16  24.30  23.83  
   PAT Margin (%)23.81  -13.24  -268.67  33.78  23.60  
   Cash Profit Margin (%)24.10  106.31  -177.74  54.88  43.27  
Performance Ratios          
   ROA(%)15.78  -0.16  -7.19  3.78  3.36  
   ROE(%)20.24  -0.25  -11.73  5.83  5.01  
   ROCE(%)20.35  0.93  -5.14  6.10  4.12  
   Asset Turnover(x)0.66  0.01  0.03  0.11  0.14  
   Sales/Fixed Asset(x)1.78  0.02  0.04  0.17  0.22  
   Working Capital/Sales(x)1.62  0.08  -0.29  -2.33  4.31  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.56  64.96  27.91  5.74  4.58  
   Receivable days297.29  0.00  146.98  34.74  15.14  
   Inventory Days0.00  0.00  0.00  52.32  28.15  
   Payable days70.37  3716.00  231.43  -183.03  44.49  
Valuation Parameters          
   PER(x)0.00  0.00  0.00  0.00  0.00  
   PCE(x)0.00  0.00  0.00  0.00  0.00  
   Price/Book(x)0.00  0.00  0.00  0.00  0.00  
   Yield(%)0  0  0  0  0  
   EV/Net Sales(x)1.11  43.25  22.06  5.31  4.53  
   EV/Core EBITDA(x)3.26  -10.40  -34.38  7.92  10.35  
   EV/EBIT(x)4.62  73.64  -14.22  11.55  18.80  
   EV/CE(x)0.68  0.80  0.60  0.57  0.62  
   M Cap / Sales0.00  0.00  0.00  0.00  0.00  
Growth Ratio          
   Net Sales Growth(%)3758.23  -66.09  -75.42  -14.06  65.70  
   Core EBITDA Growth(%)414.94  -119.75  -123.52  31.75  279.91  
   EBIT Growth(%)1472.77  112.84  -182.93  64.09  301.97  
   PAT Growth(%)7040.47  98.33  -295.48  23.01  582.00  
   EPS Growth(%)7040.50  98.33  -295.48  23.01  582.00  
Financial Stability Ratios          
   Total Debt/Equity(x)0.00  0.00  0.34  0.29  0.31  
   Current Ratio(x)2.89  5.31  0.19  0.53  4.14  
   Quick Ratio(x)2.89  5.31  0.19  0.36  2.51  
   Interest Cover(x)225.30  0.96  -1.80  2.12  96.99  
   Total Debt/Mcap(x)0  0  0  0  0